Study of the Effect of SR57667B in Patients With Alzheimer's Disease
NCT00285025
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
500
Enrollment
INDUSTRY
Sponsor class
Conditions
Alzheimer Disease
Interventions
DRUG:
SR57667B
Sponsor
Sanofi